(Q43907982)

27 November 2017

Humoral markers of inflammation and endothelial dysfunction in relation to adiposity and in vivo insulin action in Pima Indians (English)

1 reference

Coenraad Dirk Adriaan Stehouwer

27 November 2017

0 references

1 reference

1 reference

3

object named as

Coen D A Stehouwer

1 reference

27 November 2017

4

Casper G Schalkwijk

1 reference

27 November 2017

Pietro Antonio Tataranni

6

object named as

P Antonio Tataranni

1 reference

27 November 2017

Christian Weyer

1

1 reference

27 November 2017

John S Yudkin

2

1 reference

27 November 2017

Richard E Pratley

5

1 reference

27 November 2017

1 March 2002

1 reference

27 November 2017

1 reference

27 November 2017

161

1 reference

27 November 2017

233-242

1 reference

27 November 2017

1

1 reference

Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?

27 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900626-8

Body mass index, diabetes, and C-reactive protein among U.S. adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900626-8

C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900626-8

Associations of C-reactive protein with measures of obesity, insulin resistance, and subclinical atherosclerosis in healthy, middle-aged women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900626-8

Insulin action and insulinemia are closely related to the fasting complement C3, but not acylation stimulating protein concentration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900626-8

Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900626-8

Interleukin-6 and the acute phase response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900626-8

Immunological mechanisms in atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900626-8

NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900626-8

Is type II diabetes mellitus a disease of the innate immune system?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900626-8

Insulin resistance and inflammation in an evolutionary perspective: the contribution of cytokine genotype/phenotype to thriftiness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900626-8

Adhesion molecules and inflammatory injury.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900626-8

Neovascular expression of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in human atherosclerosis and their relation to intimal leukocyte content

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900626-8

Circulating adhesion molecules in disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900626-8

Tumor necrosis factor alpha inhibits signaling from the insulin receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900626-8

Elevated C-reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900626-8

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900626-8

von Willebrand Factor, C-Reactive Protein, and 5-Year Mortality in Diabetic and Nondiabetic Subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900626-8

Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900626-8

Increased levels of soluble vascular cell adhesion molecule 1 are associated with risk of cardiovascular mortality in type 2 diabetes: the Hoorn study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900626-8

Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900626-8

Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900626-8

Soluble vascular cell adhesion molecule-1 as a biohumoral correlate of atherosclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900626-8

Soluble intercellular adhesion molecule, vascular cell adhesion molecule, and impaired microvascular reactivity are early markers of vasculopathy in type 2 diabetic individuals without microalbuminuria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900626-8

The relationship between plasma glucose and insulin responses to oral glucose, LDL oxidation, and soluble intercellular adhesion molecule-1 in healthy volunteers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900626-8

Endothelial dysfunction: cause of the insulin resistance syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900626-8

Insulin sensitivity and haemostatic factors in men at high and low cardiovascular risk. The Risk Factor Intervention Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900626-8

Exaggerated early insulin release and insulin resistance in a diabetes-prone population: a metabolic comparison of Pima Indians and Caucasians

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900626-8

Coronary heart disease prevalence and its relation to risk factors in American Indians. The Strong Heart Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900626-8

The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900626-8

A high fasting plasma insulin concentration predicts type 2 diabetes independent of insulin resistance: evidence for a pathogenic role of relative hyperinsulinemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900626-8

Plasma concentration of C-reactive protein is increased in type I diabetic patients without clinical macroangiopathy and correlates with markers of endothelial dysfunction: evidence for chronic inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900626-8

Role of group II secretory phospholipase A2 in atherosclerosis: 1. Increased atherogenesis and altered lipoproteins in transgenic mice expressing group IIa phospholipase A2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900626-8

Relationship of the white blood cell count to body fat: role of leptin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900626-8

High incidence and prevalence of rheumatoid arthritis in Pima Indians

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900626-8

Elevated levels of soluble E-selectin in patients with IDDM and NIDDM: relation to metabolic control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900626-8

Effects of insulin on in vitro vascular cell adhesion molecule-1 expression and in vivo soluble VCAM-1 release.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900626-8

Endothelial dysfunction in men with small LDL particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900626-8

Plasma and lipoprotein cholesterol and triglyceride concentrations in the Pima Indians: distributions differing from those of Caucasians

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900626-8

Low incidence of fatal coronary heart disease in Pima Indians despite high prevalence of non-insulin-dependent diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900626-8

Diabetic kidney disease in Pima Indians

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900626-8

Diabetes mellitus in the Pima Indians: incidence, risk factors and pathogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900626-8

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0021-9150(01)00626-8

1 reference

27 November 2017

1 reference